PLoS ONE,
Journal Year:
2022,
Volume and Issue:
17(9), P. e0274910 - e0274910
Published: Sept. 20, 2022
It
is
well
known
that
the
presence
of
comorbidities
and
age-related
health
issues
may
hide
biochemical
metabolic
features
triggered
by
SARS-CoV-2
infection
other
diseases
associated
to
hypoxia,
as
they
are
themselves
chronic
inflammatory
conditions
potentially
disturb
homeostasis
thereby
negatively
impact
on
COVID-19
progression.
To
unveil
abnormalities
inherent
hypoxemia
caused
COVID-19,
we
here
applied
gas
chromatography
coupled
mass
spectrometry
analyze
main
changes
exhibited
a
population
male
patients
less
than
50
years
age
with
mild/moderate
severe
without
pre-existing
predispose
life-threatening
complications
from
this
infection.
Several
differences
in
serum
levels
particular
metabolites
between
normal
controls
were
identified.
These
included
increased
glutamic
acid
reduced
glutamine,
cystine,
threonic
acid,
proline
levels.
In
particular,
using
entire
metabolomic
fingerprint
obtained,
observed
glutamine/glutamate
metabolism
was
disease
severity
group
presented
lowest
higher
these
amino
acids,
respectively.
data
highlight
hypoxia-derived
alterations
provoked
absence
co-morbidities
value
determining
reactive
oxygen
species
recycling
pathways,
which
when
impaired
lead
oxidation
proteins
cell
damage.
They
also
provide
insights
new
supportive
therapies
for
disorders
involve
altered
redox
lower
better
outcomes
severity.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(9)
Published: April 30, 2024
BACKGROUNDPatients
hospitalized
for
COVID-19
exhibit
diverse
clinical
outcomes,
with
outcomes
some
individuals
diverging
over
time
even
though
their
initial
disease
severity
appears
similar
to
that
of
other
patients.
A
systematic
evaluation
molecular
and
cellular
profiles
the
full
course
can
link
immune
programs
coordination
progression
heterogeneity.METHODSWe
performed
deep
immunophenotyping
conducted
longitudinal
multiomics
modeling,
integrating
10
assays
1,152
Immunophenotyping
Assessment
in
a
Cohort
(IMPACC)
study
participants
identifying
several
cascades
were
significant
drivers
differential
outcomes.RESULTSIncreasing
was
driven
by
temporal
pattern
began
early
upregulation
immunosuppressive
metabolites
then
elevated
levels
inflammatory
cytokines,
signatures
coagulation,
formation
neutrophil
extracellular
traps,
T
cell
functional
dysregulation.
second
cascade,
predictive
28-day
mortality
among
critically
ill
patients,
characterized
reduced
total
plasma
Igs
B
cells
dysregulated
IFN
responsiveness.
We
demonstrated
balance
disruption
between
IFN-stimulated
genes
inhibitors
is
crucial
biomarker
mortality,
potentially
contributing
failure
viral
clearance
patients
fatal
illness.CONCLUSIONOur
profiling
revealed
across
omics
explain
progression,
providing
insights
inform
targeted
development
therapies
COVID-19,
especially
those
who
are
ill.TRIAL
REGISTRATIONClinicalTrials.gov
NCT04378777.FUNDINGNIH
(5R01AI135803-03,
5U19AI118608-04,
5U19AI128910-04,
4U19AI090023-11,
4U19AI118610-06,
R01AI145835-01A1S1,
5U19AI062629-17,
5U19AI057229-17,
5U19AI125357-05,
5U19AI128913-03,
3U19AI077439-13,
5U54AI142766-03,
5R01AI104870-07,
3U19AI089992-09,
3U19AI128913-03,
5T32DA018926-18);
NIAID,
NIH
(3U19AI1289130,
U19AI128913-04S1,
R01AI122220);
National
Science
Foundation
(DMS2310836).
npj Biofilms and Microbiomes,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Aug. 1, 2024
Abstract
The
clinical
course
of
COVID-19
is
variable
and
often
unpredictable.
To
test
the
hypothesis
that
disease
progression
inflammatory
responses
associate
with
alterations
in
microbiome
metabolome,
we
analyzed
metagenome,
cytokine,
transcriptome
profiles
repeated
samples
from
hospitalized
patients
uninfected
controls,
leveraged
information
post-hoc
confounder
analysis.
Severe
was
associated
a
depletion
beneficial
intestinal
microbes,
whereas
oropharyngeal
microbiota
disturbance
mainly
linked
to
antibiotic
use.
severity
also
enhanced
plasma
concentrations
kynurenine
reduced
levels
several
other
tryptophan
metabolites,
lysophosphatidylcholines,
secondary
bile
acids.
Moreover,
various
metabolites
were
Faecalibacterium
,
decrease
increase
production
cytokines.
Collectively,
our
study
identifies
correlated
metabolome
as
potential
contributor
dysregulation
severe
COVID-19.
Critical Care,
Journal Year:
2022,
Volume and Issue:
26(1)
Published: May 30, 2022
Abstract
Background
A
dysregulated
immune
response
is
emerging
as
a
key
feature
of
critical
illness
in
COVID-19.
Neutrophils
are
components
early
innate
immunity
that,
if
not
tightly
regulated,
contribute
to
uncontrolled
systemic
inflammation.
We
sought
decipher
the
role
neutrophil
phenotypes,
functions,
and
homeostasis
COVID-19
disease
severity
outcome.
Methods
By
using
flow
cytometry,
this
longitudinal
study
compares
peripheral
whole-blood
neutrophils
from
90
ICU
patients
with
those
22
SARS-CoV-2-negative
hospitalized
for
severe
community-acquired
pneumonia
(CAP)
38
healthy
controls.
also
assessed
correlations
between
these
phenotypic
functional
indicators
markers
endothelial
damage
well
severity.
Results
At
admission,
circulating
showed
continuous
basal
hyperactivation
seen
CAP
patients,
associated
higher
levels
soluble
E-
P-selectin,
which
reflect
platelet
activation.
Furthermore,
had
expanded
aged-angiogenic
reverse
transmigrated
subsets—both
involved
dysfunction
vascular
Simultaneously,
significantly
lower
oxidative
burst
bacterial
formyl
peptide.
Moreover
dying
expansion
subset
greater
impairment
than
survivors.
Conclusions
These
data
suggest
that
exhaustion
may
be
pathogenesis
identify
angiogenic
potentially
harmful
fatal
Graphic
Scientific Reports,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: July 13, 2022
The
majority
of
metabolomics
studies
to
date
have
utilised
blood
serum
or
plasma,
biofluids
that
do
not
necessarily
address
the
full
range
patient
pathologies.
Here,
correlations
between
metabolites,
salivary
metabolites
and
sebum
lipids
are
studied
for
first
time.
83
COVID-19
positive
negative
hospitalised
participants
provided
alongside
saliva
samples
analysis
by
liquid
chromatography
mass
spectrometry.
Widespread
alterations
serum-sebum
lipid
relationships
were
observed
in
versus
controls.
There
was
also
a
marked
correlation
immunostimulatory
hormone
dehydroepiandrosterone
sulphate
cohort.
analysed
herein
compared
terms
their
ability
differentiate
from
controls;
performed
best
multivariate
(sensitivity
specificity
0.97),
with
dominant
changes
triglyceride
bile
acid
levels,
concordant
other
identifying
dyslipidemia
as
hallmark
infection.
Sebum
well
0.92;
0.84),
performing
worst
0.78;
0.83).
These
findings
show
skin
profiles
coincide
dyslipidaemia
serum.
work
signposts
potential
integrated
biofluid
analyses
provide
insight
into
whole-body
atlas
pathophysiological
conditions.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Sept. 27, 2023
Post-acute
COVID-19
sequelae,
commonly
known
as
long
COVID,
encompasses
a
range
of
systemic
symptoms
experienced
by
significant
number
survivors.
The
underlying
pathophysiology
COVID
has
become
topic
intense
research
discussion.
While
chronic
inflammation
in
received
considerable
attention,
the
role
neutrophils,
which
are
most
abundant
all
immune
cells
and
primary
responders
to
inflammation,
been
unfortunately
overlooked,
perhaps
due
their
short
lifespan.
In
this
review,
we
discuss
emerging
neutrophil
extracellular
traps
(NETs)
persistent
inflammatory
response
observed
patients.
We
present
early
evidence
linking
persistence
NETs
pulmonary
fibrosis,
cardiovascular
abnormalities,
neurological
dysfunction
COVID.
Several
uncertainties
require
investigation
future
studies.
These
include
mechanisms
SARS-CoV-2
brings
about
sustained
activation
phenotypes
after
infection
resolution;
whether
heterogeneity
neutrophils
seen
acute
persists
into
phase;
presence
autoantibodies
can
induce
protect
them
from
degradation;
exert
differential,
organ-specific
effects;
specifically
NET
components
contribute
pathologies,
such
fibrosis;
senescent
drive
formation
through
pro-inflammatory
secretome
Answering
these
questions
may
pave
way
for
development
clinically
applicable
strategies
targeting
NETs,
providing
relief
health
crisis.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 4, 2023
Abstract
The
pathogenesis
of
multi-organ
dysfunction
associated
with
severe
acute
SARS-CoV-2
infection
remains
poorly
understood.
Endothelial
damage
and
microvascular
thrombosis
have
been
identified
as
drivers
COVID-19
severity,
yet
the
mechanisms
underlying
these
processes
remain
elusive.
Here
we
show
alterations
in
fluid
shear
stress-responsive
pathways
critically
ill
adults
compared
to
non-COVID
using
a
multiomics
approach.
Mechanistic
in-vitro
studies,
microvasculature-on-chip
devices,
reveal
that
plasma
from
induces
fibrinogen-dependent
red
blood
cell
aggregation
mechanically
damages
glycocalyx.
This
mechanism
appears
unique
COVID-19,
sepsis
patients
demonstrates
greater
membrane
stiffness
but
less
significant
overall
rheology.
Multiomics
analyses
pediatric
or
post-infectious
multi-inflammatory
syndrome
children
(MIS-C)
demonstrate
little
overlap
cytokine
metabolite
changes
adult
patients.
Instead,
MIS-C
strongly
upregulation.
These
findings
link
high
fibrinogen
endotheliopathy
highlight
differences
key
mediators
between
populations.
Frontiers in Molecular Biosciences,
Journal Year:
2022,
Volume and Issue:
9
Published: Nov. 3, 2022
Metabolomics
is
a
fast-developing
technique
used
in
biomedical
researches
focusing
on
pathological
mechanism
illustration
or
novel
biomarker
development
for
diseases.
The
ability
of
simultaneously
quantifying
thousands
metabolites
samples
makes
metabolomics
promising
predictive
personalized
medicine-oriented
and
applications.
Liquid
chromatography-mass
spectrometry
the
most
widely
employed
analytical
strategy
metabolomics.
In
this
current
mini-review,
we
provide
brief
update
recent
developments
applications
LC-MS
based
medicine
sector,
such
as
early
diagnosis,
molecular
phenotyping
prognostic
evaluation.
COVID-19
related
metabolomic
studies
are
also
summarized.
We
discuss
prospects
precision
researches,
well
critical
issues
that
need
to
be
addressed
when
employing
clinical
Metabolites,
Journal Year:
2022,
Volume and Issue:
12(3), P. 240 - 240
Published: March 11, 2022
Coronavirus
disease
2019
(COVID-19)
represents
a
major
public
health
crisis
that
has
caused
the
death
of
nearly
six
million
people
worldwide.
Emerging
data
have
identified
deficiency
circulating
arginine
in
patients
with
COVID-19.
Arginine
is
semi-essential
amino
acid
serves
as
key
regulator
immune
and
vascular
cell
function.
metabolized
by
nitric
oxide
(NO)
synthase
to
NO
which
plays
pivotal
role
host
defense
health,
whereas
catabolism
arginase
ornithine
contributes
suppression
disease.
Notably,
activity
upregulated
COVID-19
disease-dependent
fashion,
favoring
production
its
metabolites
from
over
synthesis
NO.
This
rewiring
metabolism
promotes
endothelial
dysfunction,
smooth
muscle
proliferation
migration,
inflammation,
vasoconstriction,
thrombosis,
arterial
thickening,
fibrosis,
stiffening,
can
lead
occlusion,
muti-organ
failure,
death.
Strategies
restore
plasma
concentration
arginine,
inhibit
activity,
and/or
enhance
bioavailability
potency
represent
promising
therapeutic
approaches
may
preserve
function
prevent
development
severe